ORMP Oramed Pharmaceuticals Inc. - Common Stock
$4,83
Preço · Ago 19, 2026
Fundamentais a partir de Ago 10, 2026
Intervalo 52 Semanas
$2–$5
89% of range
Classificação do Analista
HOLD
6 analysts
Preço-Alvo
$6
+29% upside
P/E (TTM)
0.0
ROE
37.0%
Margem de Lucro Líquido
3202.5%
Sobre Oramed Pharmaceuticals Inc. - Common Stock Visão geral da empresa da Wikipedia
Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
Ler mais
Oramed Pharmaceuticals Inc. (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
History
Oramed Pharmaceuticals was founded in 2006 by Miriam Kidron, a scientist at the Hadassah University Hospital in Jerusalem, and her son Nadav Kidron.
Product pipeline
Oramed considers its flagship product to be an oral insulin capsule developed to treat sufferers of type 2 diabetes. The Company is currently conducting Phase 3 trials, under the FDA, for oral insulin in Type 2 diabetes.
In addition to the oral insulin capsule, Oramed is developing an exenatide-based capsule designed to balance blood sugar levels and control appetite, and is conducting clinical trials for the treatment of NASH with oral insulin.
In 2021, Oramed created a subsidiary, Oravax Medical, to bring an oral Covid-19 vaccine to market.
In January 2023, a Phase 3 trial of Oramed's orally administered insulin for Type 2 diabetes patients failed, thus causing the share price to plunge. The company has mentioned that the pill worked for a subset of the population and will pursue a Phase 3 trial for that subset.
In May 2023, Ben Shapiro invested $4.7 million and was named to the board of directors.
On May 15, 2023, it was reported that Oramed's insulin pill was approved in China and will work with a Chinese firm to apply for marketing authorizations.
Subsidiaries
OraTech Pharmaceuticals is a joint venture formed by Oramed Pharmaceuticals and Hefei Tianhui Biotech, to commercialize its insulin capsule and is expected to list on the NASDAQ sometime in 2025.
Fonte: Wikipedia (Inglês), CC BY-SA 4.0 · Ver na Wikipedia ↗
ORMP Instantâneo da Ação Preço, capitalização de mercado, P/E, EPS, ROE, dívida/patrimônio, intervalo de 52 semanas
Preço
$4.83
Capitalização de Mercado
$197.7K
P/E (TTM)
0.0
EPS (TTM)
$1.50
Receita (TTM)
$2M
Rendimento div.
—
ROE
37.0%
Dívida/Capital
—
Intervalo 52 Semanas
$2 – $5
ORMP Gráfico de Preço da Ação OHLCV diário com indicadores técnicos — panorâmica, zoom e personalize sua visualização
Configure
Desempenho de 10 Anos Tendências de receita, lucro líquido, margens e EPS
Receita e Lucro Líquido
$2M
2017-08-31
→
2025-12-31
EPS
$1.50
2022-12-31
→
2025-12-31
Fluxo de caixa livre
$-9M
2019-08-31
→
2025-12-31
Margens
3202.5%
2025-12-31
→
2025-12-31
Avaliação Rácios P/E, P/S, P/B, EV/EBITDA — a ação está cara ou barata?
Métrica
Tendência de 5 anos
ORMP
Mediana de Pares
P/E (TTM)
0.0
23.4
P/S (TTM)
0.1
11.2
P/B
0.0
2.5
Price / FCF (Preço / FCF)
-0.0
—
Lucratividade Margens bruta, operacional e líquida; ROE, ROA, ROIC
Métrica
Tendência de 5 anos
ORMP
Mediana de Pares
Gross Margin (Margem Bruta)
0.65%
82.8%
Operating Margin (Margem Operacional)
-754.4%
—
Net Profit Margin (Margem de Lucro Líquido)
3202.5%
-199.7%
ROA
33.2%
-34.8%
ROE
37.0%
-33.2%
ROIC
-6.4%
—
Saúde financeira Dívida, liquidez, solvência — força do balanço patrimonial
Métrica
Tendência de 5 anos
ORMP
Mediana de Pares
Current Ratio (Índice de liquidez corrente)
7.0
1.5
Quick Ratio (Índice de Liquidez Seca)
2.7
—
Crescimento Crescimento da receita, EPS e lucro líquido: YoY, CAGR 3 anos, CAGR 5 anos
Métrica
Tendência de 5 anos
ORMP
Mediana de Pares
Revenue YoY (Receita Ano a Ano)
-50.4%
—
Revenue CAGR 3Y (CAGR Receita 3A)
-9.6%
—
Eficiência de Capital Giro de ativos, giro de estoques, giro de contas a receber
Métrica
Tendência de 5 anos
ORMP
Mediana de Pares
Dividendos Rendimento, índice de pagamento, histórico de dividendos, CAGR de 5 anos
Dividend Yield
—
Índice de Pagamento
—
CAGR Dividendos 5 anos
—
| Data ex | Valor |
|---|---|
| 16 de Janeiro de 2026 | $0,2500 |
ORMP Consenso dos analistas Opiniões de analistas otimistas e pessimistas, preço-alvo de 12 meses, potencial de alta
VENDA
6 analistas
- Compra forte 0 0,0%
- Compra 0 0,0%
- Manter 3 50,0%
- Venda 1 16,7%
- Venda forte 2 33,3%
Preço-alvo de 12 meses
1 analistas · 2026-08-17
Mín
$6.25
Máx
$6.25
Alvo mediano
$6.25
+29,4%
Alvo médio
$6.25
+29,4%
Histórico de Lucros EPS real vs. estimativa, surpresa %, taxa de acerto, próxima data de resultados
Surpresa Média
0.32%
| Período | EPS Actual | EPS est. | Surpresa |
|---|---|---|---|
| 31 de Dezembro de 2025 | $0.24 | $0.00 | 0.24% |
| 30 de Setembro de 2025 | $1.12 | $-0.04 | 1.2% |
| 30 de Junho de 2025 | $0.31 | $-0.04 | 0.35% |
| 31 de Março de 2025 | $-0.19 | $-0.01 | -0.18% |
| 31 de Dezembro de 2024 | $0.00 | $-0.03 | 0.03% |
Comparação de pares (subindústria GICS) Métricas chave vs pares do setor
| Ticker | Capitalização de Mercado | P/E | Receita YoY | Margem Líquida | ROE | Margem Bruta |
|---|---|---|---|---|---|---|
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| TTRX | $116M | -32.8 | — | — | -141.7% | — |
| ANTX | $31M | -1.0 | — | — | -57.7% | — |
| SIGA | $438M | 19.1 | -31.8% | 24.6% | 11.4% | — |
| DERM | — | -16.4 | 10.2% | -18.5% | -44.7% | — |
| LENZ | $502M | -5.6 | — | -430.2% | -33.5% | — |
| NRXP | — | — | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Fundamentos Completos Todas as métricas por ano — demonstração de resultados, balanço patrimonial, fluxo de caixa
Demonstração de Resultados 17
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | · | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Cost of Revenue | $2M | · | · | · | · | · | $90.0K | $-86.0K | $187.0K | |
| Gross Profit | $13.0K | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $6M | $9M | $28M | · | $10M | $14M | $12M | $10M | |
| SG&A Expense | $9M | $6M | $8M | $14M | · | $4M | $4M | $4M | $3M | |
| Operating Income | $-15M | $-13M | $-16M | $-41M | · | $-12M | $-15M | $-14M | $-11M | |
| Interest Expense | · | · | $2M | · | · | · | · | · | · | |
| Interest Income | · | · | $10.0K | · | · | · | · | · | · | |
| Other Non-op | $-606.0K | $-27.0K | $13.3K | $3M | · | · | · | · | · | |
| Pretax Income | $75M | $-16M | $5M | $-38M | · | $-12M | $-14M | $-13M | $-10M | |
| Income Tax | $11M | $3M | · | $100.0K | · | · | $300.0K | · | $400.0K | |
| Net Income | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| EPS (Basic) | $1.53 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| EPS (Diluted) | $1.50 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| Shares (Basic) | 41,402,997 | 40,850,446 | 40,315,068 | 38,997,649 | · | · | · | · | · | |
| Shares (Diluted) | 42,418,644 | 40,850,446 | 40,566,901 | 38,997,649 | · | · | · | · | · | |
| EBITDA | $-15M | · | $-16M | $-41M | · | $-12M | $-15M | · | · |
Balanço Patrimonial 23
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $54M | $9M | $40M | · | $19M | $3M | $5M | $4M | |
| Short-term Investments | $5M | $3M | · | · | $8M | $3M | · | $5M | · | |
| Prepaid Expense | $3M | $1M | $537.0K | $1M | · | $611.0K | $1M | $574.0K | · | |
| Current Assets | $133M | $143M | $163M | $157M | $148M | $41M | $33M | $31M | · | |
| PP&E (Net) | $586.0K | $698.0K | $873.0K | $815.0K | $388.0K | $99.0K | $24.0K | $17.0K | · | |
| Other Non-current Assets | $44.0K | $32.0K | $27.0K | · | · | · | · | · | · | |
| Total Assets | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Accounts Payable | $443.0K | $789.0K | $551.0K | $4M | $5M | $2M | $3M | $2M | · | |
| Accrued Liabilities | $1M | $402.0K | $605.0K | · | · | · | · | · | · | |
| Short-term Debt | $652.0K | $329.0K | $51M | · | · | · | $3M | $2M | · | |
| Current Liabilities | $19M | $6M | $53M | $6M | $7M | $5M | $5M | $5M | · | |
| Capital Leases | $540.0K | $156.0K | $342.0K | $647.0K | $370.0K | $31.0K | · | · | · | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | $60.0K | $63.0K | · | · | $211.0K | $271.0K | $313.0K | · | |
| Long-term Debt | · | · | · | $25.0K | $12M | · | $10M | $11M | · | |
| Total Debt | · | · | $51M | · | · | · | $3M | · | · | |
| Common Stock | $472.0K | $480.0K | $485.0K | $476.0K | $459.0K | $284.0K | $208.0K | $207.0K | · | |
| Paid-in Capital | · | · | · | $314M | $293M | $125M | · | · | · | |
| Retained Earnings | $-123M | $-177M | $-158M | $-163M | $-127M | $-93M | $-81M | $-69M | · | |
| AOCI | · | · | · | · | · | · | · | $702.0K | · | |
| Stockholders' Equity | $200M | $145M | $164M | $152M | $166M | $33M | $19M | $31M | $19M | |
| Liabilities + Equity | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Shares Outstanding | 39,275,006 | 39,920 | 40,339,000 | 39,564,000 | 38,158 | 23,675,530 | 17,383,359 | 17,369,875 | · |
Fluxo de Caixa 12
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $12M | · | $465.0K | $808.0K | $2M | $2M | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-10M | $-28M | · | $-12M | $-13M | $-15M | $-6M | |
| CapEx | $9.0K | $18.0K | $254.0K | $496.0K | · | $82.0K | $15.0K | $5.0K | $7.0K | |
| Investing Cash Flow | $5M | $106M | $-73M | $30M | · | $5M | $11M | $-7M | $4M | |
| Stock Issued | · | · | $2M | $12M | · | · | · | · | · | |
| Stock Repurchased | $5M | $2M | · | · | · | · | · | · | · | |
| Net Stock Activity | $-5M | · | $2M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-5M | $-52M | $52M | $11M | · | $24M | · | $23M | $2M | |
| Net Change in Cash | $-8M | $45M | $-31M | $13M | · | $16M | $-2M | $1M | $62.0K | |
| Taxes Paid | · | $2M | · | $2M | · | · | $300.0K | · | $400.0K | |
| Free Cash Flow | $-9M | · | $-11M | $-28M | · | $-13M | $-13M | · | · |
Lucratividade 8
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.65% | · | · | · | · | · | · | · | · | |
| Operating Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| Net Margin | 3202.5% | · | 412.3% | -1397.1% | · | -424.8% | -531.1% | · | · | |
| Pretax Margin | 3766.2% | · | 379.7% | · | · | -424.8% | -520.0% | · | · | |
| EBITDA Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| ROA | 33.2% | · | 2.9% | -22.2% | · | -29.0% | -35.0% | · | · | |
| ROE | 37.0% | · | 3.5% | -23.7% | · | -47.0% | -70.1% | · | · | |
| ROIC | -6.4% | · | · | · | · | · | -67.6% | · | · |
Liquidez e Solvência 4
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 3.1 | 27.3 | · | 8.9 | 6.3 | · | · | |
| Quick Ratio | 2.7 | · | 1.3 | 0.7 | · | 5.0 | 1.3 | · | · | |
| Debt / Equity | · | · | 0.3 | · | · | · | 0.1 | · | · | |
| Interest Coverage | · | · | -7.7 | · | · | · | · | · | · |
Eficiência 1
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · |
Taxas de Crescimento 2
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -50.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -9.6% | · | · | · | · | · | · | · | · |
Avaliação (TTM) 14
| Métrica | Tendência | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Net Income TTM | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| Market Cap | $112M | · | $93M | $476M | · | $83M | $58M | · | · | |
| Enterprise Value | · | · | $77M | · | · | · | $53M | · | · | |
| P/E | 1.9 | -5.0 | 16.5 | -12.8 | · | · | · | · | · | |
| P/S | 56.0 | · | 69.5 | 176.1 | · | 30.5 | 21.4 | · | · | |
| P/B | 0.6 | · | 0.6 | 3.1 | · | 2.5 | 3.0 | · | · | |
| P / Tangible Book | 0.6 | 0.7 | 0.6 | 3.1 | · | 2.5 | · | · | · | |
| P / Cash Flow | -12.2 | · | -9.1 | -17.0 | · | -6.6 | -4.5 | · | · | |
| P / FCF | -12.2 | · | -8.8 | -16.8 | · | -6.6 | -4.5 | · | · | |
| EV / EBITDA | · | · | -4.9 | · | · | · | -3.6 | · | · | |
| EV / FCF | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| EV / Revenue | · | · | 57.8 | · | · | · | 19.8 | · | · | |
| Earnings Yield | 52.6% | -19.8% | 6.1% | -7.8% | · | · | · | · | · |
Demonstração de Resultados 17
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | · | · | $2M | · | · | · | · | $0 | · | $674.0K | $666.0K | $681.0K | $682.0K | |
| Cost of Revenue | · | · | $0 | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | · | · | $0 | · | · | $13.0K | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $2M | $2M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $2M | $957.0K | $2M | $4M | $7M | $5M | |
| SG&A Expense | $3M | $2M | $4M | $1M | $1M | $2M | $2M | $847.0K | $2M | $2M | $2M | $3M | $2M | $1M | $3M | $3M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $11.0K | |
| Operating Income | $-3M | $-4M | $-6M | $-2M | $-2M | $-4M | $-4M | $-3M | $-3M | $-3M | $-4M | $-3M | $-4M | $-5M | $-10M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $592.0K | · | $826.0K | · | · | · | · | |
| Other Non-op | $-4.0K | $-100.0K | $-74M | $61M | · | $-143.0K | $-2M | $-15M | $14M | $4M | $-4M | $435.0K | $2M | $2M | $1M | $1M | |
| Pretax Income | $102M | $49M | $10M | $59M | $13M | $-7M | $-10M | $-19M | $11M | $2M | $13M | $-3M | $-1M | · | $-9M | $-7M | |
| Income Tax | $23M | $11M | $-212.0K | $11M | $-126.0K | $584.0K | $416.0K | $1M | $2M | · | · | · | · | · | $0 | $100.0K | |
| Net Income | $78M | $38M | $10M | $48M | $13M | $-8M | $-10M | $-20M | $9M | $2M | $13M | $-3M | $-1M | $-3M | $-8M | $-7M | |
| EPS (Basic) | $1.90 | $0.94 | $0.24 | $1.16 | $0.32 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| EPS (Diluted) | $1.84 | $0.91 | $0.25 | $1.13 | $0.31 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| Shares (Basic) | 41,040,479 | 40,773,866 | -83,325,572 | 41,756,301 | 41,743,486 | 41,228,782 | -81,842,111 | 40,896,845 | 40,959,759 | 40,835,953 | -80,397,680 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| Shares (Diluted) | 42,501,252 | 41,970,186 | -84,194,067 | 42,774,504 | 42,609,425 | 41,228,782 | -83,201,413 | 40,896,845 | 41,591,007 | 41,564,007 | -80,145,847 | 40,445,896 | 40,225,594 | 40,041,258 | -77,577,522 | 39,100,231 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-2M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-4M | $-5M | · | $-8M |
Balanço Patrimonial 22
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $13M | $46M | $52M | $16M | · | $54M | · | $10M | $19M | · | · | · | · | $40M | · | |
| Short-term Investments | $846.0K | $5M | $5M | $5M | $2M | $4M | $3M | $57M | $66M | $78M | · | $49.4K | $943.0K | $2M | · | $5M | |
| Prepaid Expense | $2M | $2M | $3M | $1M | $1M | $832.0K | $1M | $474.0K | $533.0K | $501.0K | $537.0K | $666.0K | $769.0K | · | $1M | · | |
| Current Assets | $53M | $68M | $133M | $136M | $99M | $131M | $143M | $143M | $153M | $177M | $163M | $176M | $151M | $155M | $157M | $160M | |
| PP&E (Net) | $532.0K | $561.0K | $586.0K | $614.0K | $645.0K | $671.0K | $698.0K | $718.0K | $765.0K | $819.0K | $873.0K | $923.0K | $945.0K | $977.0K | $815.0K | $535.0K | |
| Other Non-current Assets | $49.0K | $46.0K | $44.0K | $40.0K | $38.0K | $32.0K | $32.0K | · | · | · | $27.0K | · | · | · | · | · | |
| Total Assets | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Accounts Payable | $374.0K | $481.0K | $443.0K | $560.0K | $715.0K | $509.0K | $789.0K | $5M | $3M | $1M | $551.0K | $3M | $828.0K | $4M | $4M | $4M | |
| Accrued Liabilities | $1M | $1M | $1M | $585.0K | $841.0K | $800.0K | $402.0K | · | · | · | $605.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | $51M | $75M | $3.0K | $1.0K | · | · | |
| Current Liabilities | $11M | $11M | $19M | $6M | $4M | $5M | $6M | $5M | $4M | $34M | $53M | $78M | $1M | $5M | $6M | $7M | |
| Capital Leases | $484.0K | $493.0K | $540.0K | $589.0K | $648.0K | $120.0K | $156.0K | $186.0K | $236.0K | $272.0K | $342.0K | $389.0K | $488.0K | $564.0K | $647.0K | $672.0K | |
| Deferred Tax | $40M | $18M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $60.0K | $60.0K | $60.0K | · | $63.0K | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $75M | · | · | · | $5M | |
| Total Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | · | $75M | $3.0K | $1.0K | · | · | |
| Common Stock | $495.0K | $491.0K | $472.0K | $490.0K | $491.0K | $491.0K | $480.0K | $484.0K | $488.0K | $487.0K | $485.0K | $484.0K | $484.0K | $481.0K | $476.0K | $470.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | $319M | $317M | · | $308M | |
| Retained Earnings | $-7M | $-85M | $-123M | $-123M | $-171M | $-184M | $-177M | $-166M | $-147M | $-156M | $-158M | $-171M | $-168M | $-166M | $-163M | $-155M | |
| Stockholders' Equity | $317M | $238M | $200M | $203M | $155M | $141M | $146M | $156M | $177M | $167M | $164M | $149M | $152M | $151M | $152M | $154M | |
| Liabilities + Equity | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Shares Outstanding | 41,314,211 | 40,926,081 | 39,275,006 | 40,838,226 | 40,845,087 | 40,850,455 | 39,919,545 | 40,209,575 | 40,628,924 | 40,519,160 | 40,338,979 | 40,282,688 | 40,219,396 | 39,969,979 | 39,563,888 | 39,113,236 |
Fluxo de Caixa 12
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $719.0K | $800.0K | $2M | $1M | $301.0K | $1M | $1M | $1M | $852.0K | $2M | $173.0K | $3M | $3M | |
| Deferred Tax | $22M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-200.0K | $-3M | $-466.0K | $-2M | $-4M | $-4M | $-2M | $-7M | $2M | $-1M | $-1M | $-694.0K | $-3M | $-6M | $-8M | $-2M | |
| CapEx | $2.0K | $5.0K | $2.0K | $0 | $4.0K | $3.0K | $11.0K | $5.0K | $0 | $2.0K | $3.0K | $32.0K | $20.0K | $199.0K | $308.0K | $121.0K | |
| Investing Cash Flow | $4M | $-19M | $-2M | $38M | $-55M | $24M | $15M | $-34M | $95M | $30M | $30M | $-75M | $-15M | $-13M | $11M | $1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-2.0K | $0 | $2M | $4M | $-3M | |
| Stock Repurchased | · | · | $4M | $361.0K | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $78.0K | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $-10M | $-4M | $-361.0K | · | · | $-1M | $-1M | $-31M | $-19M | $-25M | $75M | $0 | $2M | $4M | $4M | |
| Net Change in Cash | $2M | $-33M | $-6M | $36M | $-59M | $20M | $12M | $-43M | $66M | $10M | $4M | $-1M | $-17M | $-16M | $7M | $3M | |
| Taxes Paid | · | · | · | $-7M | · | · | · | · | · | · | · | $527.0K | $3M | $308.0K | · | $167.0K | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · | · | $-1M | · | · | · | $-6M | · | · |
Lucratividade 8
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.65% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| Net Margin | · | · | · | · | · | -382.1% | · | · | · | · | · | · | -177.2% | -542.2% | · | -1063.5% | |
| Pretax Margin | · | · | · | · | · | -352.9% | · | · | · | · | · | · | · | · | · | -1048.8% | |
| EBITDA Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| ROA | 29.4% | 18.4% | · | 25.1% | 7.7% | -4.3% | · | -9.9% | 5.4% | 0.85% | · | -1.6% | -0.75% | -2.2% | · | -5.9% | |
| ROE | 33.1% | 20.2% | · | 26.9% | 8.0% | -5.0% | · | -12.8% | 5.6% | 0.97% | · | -2.1% | -0.78% | -2.3% | · | -6.5% | |
| ROIC | -0.67% | -1.2% | · | -0.97% | -1.6% | -3.5% | · | -2.1% | -1.5% | · | · | · | · | · | · | -5.4% |
Liquidez e Solvência 4
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 6.5 | · | 22.2 | 26.8 | 23.9 | · | 27.1 | 41.1 | 5.3 | · | 2.2 | 141.5 | 31.2 | · | 24.5 | |
| Quick Ratio | 1.5 | 1.7 | · | 9.3 | 4.8 | 0.7 | · | 10.9 | 20.4 | 2.9 | · | 0.0 | 0.9 | 0.5 | · | 0.8 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.2 | · | 0.5 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -5.0 | · | -3.5 | · | · | · | · |
Eficiência 1
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 |
Avaliação (TTM) 15
| Métrica | Tendência | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $178M | $92M | · | $34M | $-5M | $-17M | · | $-12M | $6M | $-6M | · | $-15M | $-22M | $-32M | · | $-36M | |
| Market Cap | $199M | $139M | · | $108M | $92M | $87M | · | $98M | $104M | $118M | · | $105M | $144M | $87M | · | $253M | |
| Enterprise Value | · | · | · | $51M | $74M | · | · | · | · | $54M | · | · | · | · | · | · | |
| P/E | 1.1 | 1.6 | · | 3.4 | -16.1 | -5.2 | · | -8.1 | 17.1 | -19.5 | · | -261.0 | 10.5 | 3.4 | · | 7.0 | |
| P/S | · | · | · | · | · | · | · | 36.4 | 38.7 | 43.9 | · | 39.0 | 53.4 | 32.4 | · | 94.0 | |
| P/B | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Cash Flow | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.2 | · | · | · | -15.7 | · | · | |
| P / FCF | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.1 | · | · | · | -15.2 | · | · | |
| EV / EBITDA | · | · | · | -20.9 | -29.9 | · | · | · | · | -18.2 | · | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | · | · | · | · | -36.6 | · | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | · | · | · | · | 20.0 | · | · | · | · | · | · | |
| Earnings Yield | 87.1% | 63.5% | · | 29.2% | -6.2% | -19.2% | · | -12.3% | 5.8% | -5.1% | · | -0.38% | 9.5% | 29.4% | · | 14.3% | |
| Payout Ratio | · | 27.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Demonstrações Financeiras Demonstração de resultados, balanço patrimonial, fluxo de caixa — anual, últimos 5 anos
Demonstração de Resultados
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Receita | $2M | — | $1M | $3M | — |
| Margem Bruta % | 0.65% | — | — | — | — |
| Margem Operacional % | -754.4% | — | -1176.8% | -1502.0% | — |
| Lucro líquido | $64M | $-19M | $5M | $-37M | — |
| EPS Diluído | $1.50 | $-0.48 | $0.14 | $-0.94 | — |
Balanço Patrimonial
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Dívida / Patrimônio Líquido | — | — | 0.3 | — | — |
| Índice de liquidez corrente | 7.0 | — | 3.1 | 27.3 | — |
| Índice de Liquidez Seca | 2.7 | — | 1.3 | 0.7 | — |
Fluxo de Caixa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fluxo de caixa livre | $-9M | — | $-11M | $-28M | — |
Minhas Métricas Sua lista pessoal — linhas selecionadas de Fundamentos Completos
📊
Escolha as métricas que importam para você — clique no ➕ ao lado de qualquer linha em Fundamentos Completos acima.
Sua seleção é salva e acompanha você em todos os tickers.
Investidores institucionais (13F) 88 declarantes · $64.4M total · Em 30 de Junho de 2026
Instituições que relatam a posse desta ação em seu Formulário 13F trimestral da SEC. Apenas posições compradas; um único declarante pode aparecer duas vezes para opções separadas. Grandes posições de compra/venda compensatórias geralmente refletem market-making ou inventário protegido, não convicção direcional.
Atividade institucional — Q2 2026 vs trimestre anterior
| Novas posições | Posições encerradas | Aumentou | Diminuído | Variação líquida de ações |
|---|---|---|---|---|
| 30 (+13 vs trimestre anterior) | 8 (0 vs trimestre anterior) | 19 (-1 vs trimestre anterior) | 19 (+5 vs trimestre anterior) | -209K |
Comparado a Q1 2026. Os registros do Formulário 13F da SEC devem ser feitos em até 45 dias após o final do trimestre, mais um pequeno período de tolerância para registrantes atrasados — trimestres ainda dentro desse período são ignorados em favor do par mais recente totalmente reportado.
| Instituição | Valor | Ações | % de 13F rastreado | Tipo |
|---|---|---|---|---|
| Aquamarine Financial (Cayman) Ltd | $12.083.562 | 2.512.175 | 18,77% | Ações |
| Gem Investment Advisors, LLC | $9.614.238 | 1.998.802 | 14,94% | Ações |
| MERCER GLOBAL ADVISORS INC /ADV | $9.189.697 | 1.910.540 | 14,28% | Ações |
| Murchinson Ltd. | $6.206.314 | 1.290.294 | 9,64% | Ações |
| SB Capital Management Inc | $5.415.000 | 1.900.000 | 8,41% | Ações |
| BML Capital Management, LLC | $4.166.754 | 866.269 | 6,47% | Ações |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.783.249 | 578.638 | 4,32% | Ações |
| GEODE CAPITAL MANAGEMENT, LLC | $2.162.008 | 449.482 | 3,36% | Ações |
| STATE STREET CORP | $1.164.501 | 242.100 | 1,81% | Ações |
| Rathbones Group PLC | $1.120.816 | 233.018 | 1,74% | Ações |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.105.732 | 229.882 | 1,72% | Ações |
| GOLDMAN SACHS GROUP INC | $950.908 | 197.694 | 1,48% | Ações |
| RENAISSANCE TECHNOLOGIES LLC | $884.078 | 183.800 | 1,37% | Ações |
| DIMENSIONAL FUND ADVISORS LP | $784.896 | 163.180 | 1,22% | Ações |
| STRS OHIO | $643.578 | 133.800 | 1,00% | Ações |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $495.247 | 102.962 | 0,77% | Ações |
| JANE STREET GROUP, LLC | $470.606 | 97.839 | 0,73% | Ações |
| Hillsdale Investment Management Inc. | $429.533 | 89.300 | 0,67% | Ações |
| RITHOLTZ WEALTH MANAGEMENT | $405.709 | 84.347 | 0,63% | Ações |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $402.280 | 83.634 | 0,63% | Ações |
| AMERICAN CENTURY COMPANIES INC | $287.518 | 59.775 | 0,45% | Ações |
| XTX Topco Ltd | $240.130 | 49.923 | 0,37% | Ações |
| Nuveen, LLC | $223.203 | 46.404 | 0,35% | Ações |
| DEUTSCHE BANK AG\ | $159.682 | 33.198 | 0,25% | Ações |
| PRELUDE CAPITAL MANAGEMENT, LLC | $157.350 | 32.713 | 0,24% | Ações |
| BAILARD, INC. | $156.219 | 32.478 | 0,24% | Ações |
| RHUMBLINE ADVISERS | $147.281 | 30.621 | 0,23% | Ações |
| Bank of New York Mellon Corp | $143.016 | 29.733 | 0,22% | Ações |
| ALGERT GLOBAL LLC | $139.288 | 28.958 | 0,22% | Ações |
| WELLS FARGO & COMPANY/MN | $137.080 | 28.499 | 0,21% | Ações |
| Connor, Clark & Lunn Investment Management Ltd. | $121.246 | 25.207 | 0,19% | Ações |
| CITADEL ADVISORS LLC | $120.250 | 25.000 | 0,19% | Opção de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $107.263 | 22.300 | 0,17% | Ações |
| MILLENNIUM MANAGEMENT LLC | $105.151 | 21.861 | 0,16% | Ações |
| PNC Financial Services Group, Inc. | $101.972 | 21.200 | 0,16% | Ações |
| Redwood Family Wealth LLC | $99.783 | 20.745 | 0,16% | Ações |
| BANK OF AMERICA CORP /DE/ | $91.621 | 19.048 | 0,14% | Ações |
| MORGAN STANLEY | $87.994 | 18.294 | 0,14% | Ações |
| Sage Capital Management, LLC | $86.474 | 17.977 | 0,13% | Ações |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $75.378 | 15.671 | 0,12% | Ações |
| VANGUARD FIDUCIARY TRUST CO | $67.811 | 14.098 | 0,11% | Ações |
| CITIGROUP INC | $66.590 | 13.844 | 0,10% | Ações |
| JPMORGAN CHASE & CO | $65.461 | 14.108 | 0,10% | Ações |
| Invesco Ltd. | $65.272 | 13.570 | 0,10% | Ações |
| Y-Intercept (Hong Kong) Ltd | $61.650 | 12.817 | 0,10% | Ações |
| Engineers Gate Manager LP | $61.077 | 12.698 | 0,09% | Ações |
| Altshuler Shaham Ltd | $53.925 | 11.211 | 0,08% | Ações |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $52.096 | 12.895 | 0,08% | Ações |
| Glass Jacobson Investment Advisors llc | $50.698 | 10.540 | 0,08% | Ações |
| Police & Firemen's Retirement System of New Jersey | $50.115 | 10.419 | 0,08% | Ações |
| MARSHALL WACE, LLP | $50.024 | 10.400 | 0,08% | Ações |
| Hudson Bay Capital Management LP | $49.375 | 10.265 | 0,08% | Ações |
| BNP PARIBAS FINANCIAL MARKETS | $47.706 | 9.918 | 0,07% | Ações |
| Steward Partners Investment Advisory, LLC | $42.453 | 8.826 | 0,07% | Ações |
| BARCLAYS PLC | $27.917 | 5.804 | 0,04% | Ações |
| NEW YORK STATE COMMON RETIREMENT FUND | $25.974 | 5.400 | 0,04% | Ações |
| NORTHERN TRUST CORP | $25.503 | 5.302 | 0,04% | Ações |
| Tower Research Capital LLC (TRC) | $23.218 | 4.827 | 0,04% | Ações |
| OSAIC HOLDINGS, INC. | $20.283 | 4.217 | 0,03% | Ações |
| FEDERATED HERMES, INC. | $19.221 | 3.996 | 0,03% | Ações |
| N.E.W. Advisory Services LLC | $16.495 | 3.429 | 0,03% | Ações |
| Legal & General Group Plc | $15.979 | 3.322 | 0,02% | Ações |
| CITADEL ADVISORS LLC | $15.565 | 3.236 | 0,02% | Ações |
| Ameritas Investment Partners, Inc. | $14.853 | 3.088 | 0,02% | Ações |
| HUNTINGTON NATIONAL BANK | $14.440 | 3.002 | 0,02% | Ações |
| Pioneer Family Office, LLC | $14.430 | 3.000 | 0,02% | Ações |
| Russell Investments Group, Ltd. | $13.088 | 2.721 | 0,02% | Ações |
| UBS Group AG | $12.987 | 2.700 | 0,02% | Ações |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $7.576 | 1.575 | 0,01% | Ações |
| MetLife Investment Management, LLC | $7.037 | 1.463 | 0,01% | Ações |
| BlackRock, Inc. | $6.768 | 1.407 | 0,01% | Ações |
| ROYAL BANK OF CANADA | $6.000 | 1.246 | 0,01% | Ações |
| MCF Advisors LLC | $5.162 | 1.073 | 0,01% | Ações |
| Caitlin John, LLC | $4.810 | 1.000 | 0,01% | Ações |
| McIlrath & Eck, LLC | $3.400 | 1.000 | 0,01% | Ações |
| Sterling Capital Management LLC | $3.300 | 686 | 0,01% | Ações |
| IFP Advisors, Inc | $2.405 | 500 | 0,00% | Ações |
| PROEQUITIES, INC. | $2.310 | 1.000 | 0,00% | Ações |
| Golden State Wealth Management, LLC | $1.458 | 303 | 0,00% | Ações |
| JONES FINANCIAL COMPANIES LLLP | $999 | 214 | 0,00% | Ações |
| HRT FINANCIAL LP | $469 | 97.582 | 0,00% | Ações |
| FMR LLC | $332 | 69 | 0,00% | Ações |
| SBI Securities Co., Ltd. | $284 | 59 | 0,00% | Ações |
| PRICE T ROWE ASSOCIATES INC /MD/ | $135 | 27.909 | 0,00% | Ações |
| TrinityBridge Ltd | $56 | 11.675 | 0,00% | Ações |
| HARBOUR INVESTMENTS, INC. | $48 | 10 | 0,00% | Ações |
| Caitong International Asset Management Co., Ltd | $29 | 6 | 0,00% | Ações |
| ACADIAN ASSET MANAGEMENT LLC | $8 | 1.691 | 0,00% | Ações |
Executivos da empresa 30 insiders · 13 diretores · 16 conselheiros
| Investidor com informação privilegiada | Função | Última atividade | Ações detidas | Compras 12m | Vendas 12m | Líquido 12m |
|---|---|---|---|---|---|---|
| Nadav Kidron | President and CEO | 30 de Março de 2026 F | 3.422.243 | 0 | 0 | $0 |
| Avraham Gabay | Chief Financial Officer | 1 de Julho de 2026 S | 671.785 | 0 | 1 | $-330.854 |
| David Silberman | Chief Financial Officer | 4 de Janeiro de 2024 A | 366.500 | 0 | 0 | $0 |
| Hilla Eisenberg | CFO, Treasurer and Secretary | 26 de Fevereiro de 2019 A | — | 0 | 0 | $0 |
| Yifat Hen Zommer | CFO, Treasurer and Secretary | 30 de Junho de 2017 A | 46.560 | 0 | 0 | $0 |
| Chaime Orlev | CFO, Treasurer and Secretary | 12 de Outubro de 2008 A | — | 0 | 0 | $0 |
| Joshua Hexter | COO & CBO | 2 de Julho de 2026 M | 1.073.384 | 0 | 1 | $-611.020 |
| Miriam Kidron | Chief Scientific Officer | 30 de Março de 2026 F | 1.133.138 | 0 | 0 | $0 |
| Netanel Derovan | Chief Legal Officer | 26 de Maio de 2023 A | 149.500 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 3 de Janeiro de 2023 S | 126.143 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 3 de Janeiro de 2022 A | 109.468 | 0 | 0 | $0 |
| Mark Daniel Hasleton | VP Business Development | 26 de Fevereiro de 2019 A | — | 0 | 0 | $0 |
| Ronald Edward Law | Chief Strategy Officer | 20 de Março de 2017 A | — | 0 | 0 | $0 |
| Yehuda Reznick | Conselheiro | 31 de Dezembro de 2025 A | 105.180 | 0 | 0 | $0 |
| Daniel Aghion | Conselheiro | 31 de Dezembro de 2025 A | 113.441 | 0 | 0 | $0 |
| Benjamin Shapiro | Conselheiro | 31 de Dezembro de 2025 A | 123.220 | 0 | 0 | $0 |
| Arie Mayer | Conselheiro | 31 de Dezembro de 2025 A | 168.009 | 0 | 0 | $0 |
| Leonard Sank | Conselheiro | 5 de Junho de 2025 A | 134.531 | 0 | 0 | $0 |
| Yadin Rozov | Conselheiro | 4 de Janeiro de 2024 A | 155.320 | 0 | 0 | $0 |
| Kevin Rakin | Conselheiro | 21 de Março de 2022 S | 46.661 | 0 | 0 | $0 |
| Aviad Friedman | Conselheiro | 3 de Janeiro de 2022 G | 0 | 0 | 0 | $0 |
| Gao Xiaoming | Conselheiro | 8 de Janeiro de 2020 A | — | 0 | 0 | $0 |
| David Mark Slager | Conselheiro | 15 de Abril de 2019 A | 1.316.328 | 0 | 0 | $0 |
| Xiaopeng Li | Conselheiro | 2 de Agosto de 2017 P | 206.350 | 0 | 0 | $0 |
| Harold Jacob | Conselheiro | 10 de Março de 2016 S | 16.396 | 0 | 0 | $0 |
| Michael Berelowitz | Conselheiro | 9 de Dezembro de 2015 S | 22.896 | 0 | 0 | $0 |
| Gerald M Ostrov | Conselheiro | 23 de Fevereiro de 2015 A | 24.896 | 0 | 0 | $0 |
| REGALS CAPITAL MANAGEMENT LP | Detentor de 10% | 23 de Dezembro de 2015 X | 1.186.823 | 0 | 0 | $0 |
| Zeev Bronfeld | Detentor de 10% | 27 de Setembro de 2011 S | 5.808.517 | 0 | 0 | $0 |
| Michael Young | — | 27 de Maio de 2004 S | 0 | 0 | 0 | $0 |
Executivos de declarações SEC Formulário 3/4/5; líquido = apenas P/V de mercado aberto
Ativistas e proprietários de 5%+ 9 participações
Investidores que apresentaram o Schedule 13D da SEC — propriedade benéfica acima de 5% com a intenção de influenciar o emissor (participações ativistas, campanhas no conselho, M&A). Cada linha mostra o estado mais recente conhecido da posição desse declarante.
| Declarante | Declarado | Participação | Status | Propósito | Declaração |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 22 de Julho de 2026 | 3,30% | Emenda | — | SEC |
| Nadav Kidron ×8 declarações | 28 de Agosto de 2025 | 7,60% | Emenda | — | SEC |
| Regals Capital Management LP, Regals Fund LP, David M. Slager ×2 declarações | 20 de Julho de 2018 | — | Declaração inicial | — | SEC |
| Hefei Tianhui Incubator of Technologies Co., Ltd | 6 de Janeiro de 2016 | — | Declaração inicial | — | SEC |
| Leonard Sank | 15 de Dezembro de 2014 | — | Declaração inicial | Investimento passivo | SEC |
| Miriam Kidron ×2 declarações | 3 de Fevereiro de 2014 | — | Declaração inicial | — | SEC |
| Zeev Bronfeld | 6 de Março de 2006 | — | Declaração inicial | Investimento passivo | SEC |
| Pessoa de relato não divulgada | 10 de Junho de 2004 | — | Declaração inicial | — | SEC |
| Pessoa de relato não divulgada | 10 de Junho de 2004 | — | Declaração inicial | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Participação em ETFs Detido por 14 ETFs
O peso reflete apenas participações diretas em ações (N-PORT); fundos alavancados ou baseados em derivativos podem deter exposição adicional a swaps não mostrada.
| Fundo | Peso | Unidades | Em | Fonte |
|---|---|---|---|---|
| AVSC · AMERICAN CENTURY ETF TRUST | 0,00% | 28.155 NS | 31 de Maio de 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 26.896 NS | 30 de Abril de 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.523 NS | 30 de Abril de 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 36.536 NS | 30 de Abril de 2026 | N-PORT |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 4.152 NS | 31 de Maio de 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3.431 NS | 30 de Abril de 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 30 de Abril de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de Julho de 2026 | Diário |
| VTWV · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de Julho de 2026 | Diário |
| VTHR · VANGUARD SCOTTSDALE FUNDS | — | — | 15 de Julho de 2026 | Diário |
| IWN · iShares Trust | — | — | 17 de Agosto de 2026 | Diário |
| IWM · iShares Trust | — | — | 18 de Agosto de 2026 | Diário |
| IWC · iShares Trust | — | — | 18 de Agosto de 2026 | Diário |
| OMFS · Invesco Exchange-Traded Self-Indexe… | — | — | 13 de Julho de 2026 | Diário |